Pharming Group N.V. Gross Profit

• Pharming Group N.V. showed an increase of +18.9% in Gross Profit from 2023 to 2024.
• This data is from Pharming Group N.V.'s annual report (Form 10-K), filed with the SEC on April 3, 2025.
• XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2018 to 2024), Pharming Group N.V.'s Gross Profit has grown by 131.8%.
• Historical annual values: Fiscal year 2024: $261.80 million | Fiscal year 2023: $220.10 million | Fiscal year 2022: $188.06 million | Fiscal year 2021: $177.73 million | Fiscal year 2020: $188.64 million | Fiscal year 2019: $147.67 million | Fiscal year 2018: $112.95 million.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026